Novo Nordisk/Asterias Biotherapeutics - Tenant Renovation and Expansion
Courtesy of MAI Construction.
Novo Nordisk/Asterias Biotherapeutics - Tenant Renovation and Expansion
Courtesy of MAI Construction.
Novo Nordisk/Asterias Biotherapeutics - Tenant Renovation and Expansion
Courtesy of MAI Construction.
Novo Nordisk/Asterias Biotherapeutics - Tenant Renovation and Expansion
Courtesy of MAI Construction.
Novo Nordisk/Asterias Biotherapeutics - Tenant Renovation and Expansion
Courtesy of MAI Construction.
Novo Nordisk/Asterias Biotherapeutics - Tenant Renovation and Expansion
Courtesy of MAI Construction.
Novo Nordisk/Asterias Biotherapeutics - Tenant Renovation and Expansion
Courtesy of MAI Construction.
Novo Nordisk/Asterias Biotherapeutics - Tenant Renovation and Expansion
Courtesy of MAI Construction.
Novo Nordisk completed a $5.1 million tenant renovation and expansion project in March of 2020 in Fremont, Calif. In just four months, MAI Construction remodeled the subleased 44,000-sf facility to provide Asterias Biotherapeutics with leading-edge research, production, and office spaces to support the creation of innovative stem cell therapies. The four-phase project included the construction of new cGMP Grade B manufacturing labs, as well as a materials lift and canopy for the area's shipping and receiving area. New finishes were installed in two cGMP labs, quality control labs, CNC corridors, and locker rooms. The office area was renovated to provide collaborative open workspaces and a new break area. Additionally, the stair-opening concrete deck was widened and expanded to better accommodate the delivery of equipment to the second-floor lab spaces. Novo Nordisk is based in Bagsværd, Denmark.
